NO761681L - - Google Patents
Info
- Publication number
- NO761681L NO761681L NO761681A NO761681A NO761681L NO 761681 L NO761681 L NO 761681L NO 761681 A NO761681 A NO 761681A NO 761681 A NO761681 A NO 761681A NO 761681 L NO761681 L NO 761681L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- formula
- rifamycin
- hydrogen
- hours
- Prior art date
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 24
- 150000001875 compounds Chemical class 0.000 claims description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 239000011541 reaction mixture Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- -1 Rifamycin compound Chemical class 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 229930189077 Rifamycin Natural products 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 229960003292 rifamycin Drugs 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 2
- BTVYFIMKUHNOBZ-ZDHWWVNNSA-N Rifamycin S Natural products COC1C=COC2(C)Oc3c(C)c(O)c4C(=O)C(=CC(=O)c4c3C2=O)NC(=O)C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(=O)C)C1C)C BTVYFIMKUHNOBZ-ZDHWWVNNSA-N 0.000 claims 1
- 150000002170 ethers Chemical class 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical class OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- SMPJCQGFZSDIHE-GVDHMVJUSA-N [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-amino-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl] acetate Chemical compound O=C1C(C(O)=C2C)=C3C(=O)C(N)=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O SMPJCQGFZSDIHE-GVDHMVJUSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- BCNLNCHALTVDMC-UHFFFAOYSA-N benzene;methanol;4-methylpentan-2-one Chemical compound OC.C1=CC=CC=C1.CC(C)CC(C)=O BCNLNCHALTVDMC-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000786363 Rhampholeon spectrum Species 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- UBHZUDXTHNMNLD-UHFFFAOYSA-N dimethylsilane Chemical compound C[SiH2]C UBHZUDXTHNMNLD-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT05155/75A IT1048565B (it) | 1975-05-15 | 1975-05-15 | Amine aromatiche |
Publications (1)
Publication Number | Publication Date |
---|---|
NO761681L true NO761681L (de) | 1976-11-16 |
Family
ID=11118523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO761681A NO761681L (de) | 1975-05-15 | 1976-05-14 |
Country Status (24)
Country | Link |
---|---|
US (1) | US4017481A (de) |
JP (1) | JPS51141897A (de) |
AR (1) | AR211013A1 (de) |
AT (1) | AT343808B (de) |
BE (1) | BE841548A (de) |
CA (1) | CA1057749A (de) |
CH (1) | CH622022A5 (de) |
DE (1) | DE2620782C2 (de) |
DK (1) | DK215676A (de) |
ES (1) | ES448421A1 (de) |
FI (1) | FI761176A (de) |
FR (1) | FR2311018A1 (de) |
GB (1) | GB1534075A (de) |
HU (1) | HU171395B (de) |
IE (1) | IE42980B1 (de) |
IL (1) | IL49516A (de) |
IN (1) | IN143142B (de) |
IT (1) | IT1048565B (de) |
NL (1) | NL7605142A (de) |
NO (1) | NO761681L (de) |
PT (1) | PT65102B (de) |
SE (1) | SE7604755L (de) |
SU (1) | SU598565A3 (de) |
ZA (1) | ZA762553B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK345977A (da) * | 1976-09-30 | 1978-03-31 | Archifar Ind Chim Trentino | G rifamycinforbindelser og fremgangsmaade til deres fremstillin |
CH629212A5 (it) * | 1976-10-18 | 1982-04-15 | Erba Farmitalia | Procedimento per la preparazione di composti di rifamicina. |
GB1576886A (en) * | 1977-04-20 | 1980-10-15 | Lepetit Spa | Rifamycin derivatives |
IT1090772B (it) * | 1977-12-20 | 1985-06-26 | Alfa Farmaceutici Spa | Derivati della rifamicina e procedimento per la loro preparazione |
BE886395A (fr) * | 1980-02-13 | 1981-03-16 | Erba Farmitalia | Derives de rifamycine |
DE3228883A1 (de) * | 1981-08-26 | 1983-03-10 | Hydrocarbon Research Inc., 08648 Lawrenceville, N.J. | Verfahren zur herstellung von d-fructose |
IT1201963B (it) * | 1983-03-24 | 1989-02-02 | Prodotti Antibiotici Spa | Derivati delle rifamicine e procedimento per la loro preparazione |
US4743619A (en) * | 1985-08-29 | 1988-05-10 | American Home Products Corporation | Method of treating hepatitis |
US4631290A (en) * | 1985-08-29 | 1986-12-23 | American Home Products Corporation | Method of treating hepatitis |
US7122525B2 (en) * | 2001-11-21 | 2006-10-17 | Activbiotics, Inc. | Targeted therapeutics and uses thereof |
US7820652B2 (en) * | 2003-09-24 | 2010-10-26 | Activbiotics Pharma, Llc | Regimen for the administration of rifamycin-class antibiotics |
ITMI20071435A1 (it) * | 2007-07-17 | 2009-01-18 | Segix Italia Srl | Nuovi farmaci ad attivita' anticolestatica |
CN105001236B (zh) * | 2015-06-26 | 2017-05-31 | 重庆华邦制药有限公司 | 3‑氨基‑利福霉素s的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH512510A (de) * | 1965-08-24 | 1971-09-15 | Ciba Geigy Ag | Verfahren zur Herstellung von in 3-Stellung durch eine unsubstituierte oder substituierte Aminogruppe substituierten Derivaten von Rifamycin-S und Rifamycin-SV |
GB1316689A (en) * | 1971-01-18 | 1973-05-09 | Lepetit Spa | Trifamycin derivatives |
-
1975
- 1975-05-15 IT IT05155/75A patent/IT1048565B/it active
-
1976
- 1976-04-23 IE IE856/76A patent/IE42980B1/en unknown
- 1976-04-26 SE SE7604755A patent/SE7604755L/xx unknown
- 1976-04-27 US US05/680,771 patent/US4017481A/en not_active Expired - Lifetime
- 1976-04-27 GB GB16969/76A patent/GB1534075A/en not_active Expired
- 1976-04-28 FI FI761176A patent/FI761176A/fi not_active Application Discontinuation
- 1976-04-28 ZA ZA762553A patent/ZA762553B/xx unknown
- 1976-04-30 IN IN763/CAL/76A patent/IN143142B/en unknown
- 1976-05-03 IL IL49516A patent/IL49516A/xx unknown
- 1976-05-03 CA CA251,689A patent/CA1057749A/en not_active Expired
- 1976-05-05 AR AR263203A patent/AR211013A1/es active
- 1976-05-06 CH CH568376A patent/CH622022A5/it not_active IP Right Cessation
- 1976-05-06 BE BE166810A patent/BE841548A/xx unknown
- 1976-05-07 FR FR7613690A patent/FR2311018A1/fr active Granted
- 1976-05-11 AT AT343276A patent/AT343808B/de not_active IP Right Cessation
- 1976-05-11 DE DE2620782A patent/DE2620782C2/de not_active Expired
- 1976-05-13 NL NL7605142A patent/NL7605142A/xx active Search and Examination
- 1976-05-13 DK DK215676A patent/DK215676A/da unknown
- 1976-05-14 NO NO761681A patent/NO761681L/no unknown
- 1976-05-14 JP JP51055227A patent/JPS51141897A/ja active Granted
- 1976-05-14 PT PT65102A patent/PT65102B/pt unknown
- 1976-05-14 SU SU762356006A patent/SU598565A3/ru active
- 1976-05-14 ES ES448421A patent/ES448421A1/es not_active Expired
- 1976-05-14 HU HU76AI00000256A patent/HU171395B/hu unknown
Also Published As
Publication number | Publication date |
---|---|
FI761176A (de) | 1976-11-16 |
IE42980L (en) | 1976-11-15 |
GB1534075A (en) | 1978-11-29 |
FR2311018B1 (de) | 1979-05-25 |
DE2620782C2 (de) | 1986-10-09 |
CA1057749A (en) | 1979-07-03 |
IT1048565B (it) | 1980-12-20 |
AR211013A1 (es) | 1977-10-14 |
PT65102A (en) | 1976-06-01 |
IL49516A (en) | 1979-10-31 |
US4017481A (en) | 1977-04-12 |
DK215676A (da) | 1976-11-16 |
SU598565A3 (ru) | 1978-03-15 |
ZA762553B (en) | 1977-04-27 |
PT65102B (en) | 1977-09-14 |
IN143142B (de) | 1977-10-08 |
ATA343276A (de) | 1977-10-15 |
FR2311018A1 (fr) | 1976-12-10 |
DE2620782A1 (de) | 1976-11-25 |
IL49516A0 (en) | 1976-07-30 |
NL7605142A (nl) | 1976-11-17 |
ES448421A1 (es) | 1977-07-01 |
IE42980B1 (en) | 1980-11-19 |
HU171395B (hu) | 1978-01-28 |
CH622022A5 (de) | 1981-03-13 |
JPS51141897A (en) | 1976-12-07 |
BE841548A (fr) | 1976-09-01 |
AT343808B (de) | 1978-06-26 |
AU1357476A (en) | 1977-11-10 |
SE7604755L (sv) | 1976-11-16 |
JPS623154B2 (de) | 1987-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Molinski et al. | Varamines A and B, new cytotoxic thioalkaloids from Lissoclinum vareau | |
NO761681L (de) | ||
US4219478A (en) | Rifamycin compounds | |
GrÄFe et al. | Isolation and structure elucidation of 6-(3'-methylbuten-2'-yl) isatin, an unusual metabolite from Streptomyces albus | |
CA1081218A (en) | Rifamycin compounds | |
Alcalde et al. | A direct synthetic approach to novel quadrupolar [14] azolophanes | |
De Amici et al. | Face selectivity of the nitrile oxide cycloaddition to unsaturated sugars | |
YONEDA et al. | A convenient synthesis of toxoflavins, toxoflavin 4-oxides and 1-demethyltoxoflavins | |
Roy et al. | Aranorosinol A and aranorosinol B, two new metabolites from Pseudoarachniotus roseus: production, isolation, structure elucidation and biological properties | |
GB1561299A (en) | Rifamycin compounds | |
CA1182450A (en) | Cytostatic vinblastine compounds and processes for their preparation | |
Gasco et al. | The Reduction of benzofuroxans by ferrous salts and by thiophenol | |
Rinehart Jr et al. | Synthesis of phenazine and phenoxazinone derivatives of geldanamycin as potential polymerase inhibitors | |
Sudarsanam et al. | Nitroimidazoles: Part XI. some halonitro-& dinitroimidazoles | |
KR800000907B1 (ko) | 리파마이신 화합물의 제조방법 | |
Chapyshev et al. | Effect of electronic factors on 1, 3-dipolar cycloaddition of 2, 4, 6-triazidopyridines to tert-butylphosphaacetylene | |
WATANABE et al. | Stable Sulfur Ylides. IV. Reaction of Dimethylsulfonium Acetylmethoxycarbonylmethylide and Dimethylsulfonium Diacetylmethylide with Quinoline 1-Oxide | |
Kaminskii et al. | Synthesis of pyrrolo [1, 2-a] quinoxaline derivatives by the reaction of 2-hydroxy-1, 5-diketones with o-phenylenediamine | |
Díaz‐Guerra et al. | Half‐Wave Potentials of 1‐AZA‐and 1, 8‐Diazaanthraquinones | |
Weintraub | Heterocycles. 13. synthesis of [1, 2‐d] triazolo steroids | |
Agadzhanyan et al. | Synthesis and transformations of polyhedral compounds. 14. Opening of hexahydropyrimidine ring of 2-substituted 1, 3-diazaadamantanes by electrophilic reagents | |
KR790001261B1 (ko) | 리파 마이신 화합물의 제조방법 | |
SAWAYAMA et al. | The Structures of Isatylidene-3-mercaptoacetic Acid and Its Related Compounds | |
Hatta et al. | Synthesis of dithia‐and tetrathiacyclophanes incorporating isoxazole units | |
De Koning et al. | The ansamycins: synthesis of the naphthoquinonoid nucleus of rifamycin W; crystal structure verification of a key naphthalenic intermediate |